All Curated Mutation Sites in SARS-CoV-2

Back to Mutation Home

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in SARS-CoV-2 related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Furin cleavage site

Methyltransferase

Non-coding region

Keyword: COVID-19-40083630

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	40083630	D796Y	S	S	COVID-19	G L	View
2	40083630	N764K	S	S	COVID-19	G L	View
3	40083630	N969K	S	S	COVID-19	G L	View
4	40083630	Q954H	S	S	COVID-19	G L	View
5	40083630	P681H	S	S	COVID-19	G L	View
6	40083630	E484A	RBD	S	COVID-19	G L	View
7	40083630	G339D	RBD	S	COVID-19	G L	View
8	40083630	K417N	RBD	S	COVID-19	G L	View
9	40083630	N440K	RBD	S	COVID-19	G L	View
10	40083630	N501Y	RBD	S	COVID-19	G L	View
11	40083630	Q498R	RBD	S	COVID-19	G L	View
12	40083630	S371F	RBD	S	COVID-19	G L	View
13	40083630	S373P	RBD	S	COVID-19	G L	View
14	40083630	S375F	RBD	S	COVID-19	G L	View
15	40083630	S477N	RBD	S	COVID-19	G L	View
16	40083630	T478K	RBD	S	COVID-19	G L	View
17	40083630	Y505H	RBD	S	COVID-19	G L	View

Contents
Description

The table shows all curated mutation sites of SARS-CoV-2 in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.